Quantitative analysis of localization and nuclear aggregate formation induced by GFP-lamin a mutant proteins in living HeLa cells

Journal of Cellular Biochemistry

Volumn 98, Issue 4, 2006, Pages 810-826

  Hubner S ^a,b   Eam, J E ^a   Wagstaff, K M ^a   Jans, D A ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

HGPS; Intermediate filaments; Lamin A; Laminopathy; Nuclear aggregates; Nuclear envelope

Indexed keywords

ARGININE; ASPARAGINE; CELL PROTEIN; GREEN FLUORESCENT PROTEIN; HISTONE H2A; HISTONE H2B; HYBRID PROTEIN; LAMIN A; LYSINE; MUTANT PROTEIN; PROGERIN; UNCLASSIFIED DRUG;

ARTICLE; CELL NUCLEUS; DELETION MUTANT; GENE OVEREXPRESSION; GENETIC DISORDER; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; LAMINOPATHY; MISSENSE MUTATION; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROGERIA; PROTEIN AGGREGATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; TISSUE SPECIFICITY;

ACTIVE TRANSPORT, CELL NUCLEUS; GREEN FLUORESCENT PROTEINS; HELA CELLS; HISTONES; HUMANS; LAMIN TYPE A; MICROSCOPY, FLUORESCENCE; MUTAGENESIS; MUTATION, MISSENSE; NUCLEAR LAMINA; PROGERIA; RECOMBINANT FUSION PROTEINS;

EID: 33745631245     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20791     Document Type: Article

References (78)

1. Bechert K, Lagos-Quintana M, Harborth J, Weber K, Osborn M. 2003. Effects of expressinglamin A mutant protein causing Emery-Dreifuss muscular dystrophy and familial partial lipodystrophy in HeLa cells. Exp Cell Res 286:75-86.
2. Beck LA, Hosick TJ, Sinensky M. 1990. Isoprenylation is required for the processing of the lamin A precursor. J Cell Biol 110:1489-1499.
3. Bonne G, Di Barletta MR, Varnous S, Becane HM, Hammouda EH, Merlini L, Muntoni F, Greenberg CR, Gary F, Urtizberea JA, Duboc D, Fardeau M, Toniolo D, Schwartz K. 1999. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet 21:285-288.
4. Bonne G, Mercuri E, Muchir A, Urtizberea A, Becane HM, Recan D, Merlini L, Wehnert M, Boor R, Reuner U, Vorgerd M, Wicklein EM, Eymard B, Duboc D, Penisson-Besnier I, Cuisset JM, Ferrer X, Desguerre I, Lacombe D, Bushby K, Pollitt C, Toniolo D, Fardeau M, Schwartz K, Muntoni F. 2000. Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene. Ann Neurol 48:170-180.
5. Bridger JM, Kill IR. 2004. Aging of Hutchinson-Gilford progeria syndrome fibroblasts is characterised by hyperproliferation and increased apoptosis. Exp Gerontol 39:717-724.
6. Bridger JM, Kill IR, O'Farrell M, Hutchison CJ. 1993. Internal lamin structures within G1 nuclei of human dermal fibroblasts. J Cell Sci 104(Pt 2):297-306.
7. -/- cells is caused by defective nucleo-cytoskeletal integrity: Implications for the development of laminopathies. Hum Mol Genet 13:2567-2580.
8. Broers JL, Kuijpers HJ, Ostlund C, Worman HJ, Endert J, Ramaekers FC. 2005. Both lamin A and lamin C mutations cause lamina instability as well as loss of internal nuclear lamin organization. Exp Cell Res 304:582-592.
9. Burke B. 1990. On the cell-free association of lamins A and C with metaphase chromosomes. Exp Cell Res 186:169-176.
10. Cao H, Hegele RA. 2000. Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum Mol Genet 9:109-112.
11. Cao H, Hegele RA. 2003. LMNA is mutated in Hutchinson-Gilford progeria, (MIM 176670) but not in Wiedemann-Rautenstrauch progeroid syndrome (MIM 264090). J Hum Genet 48:271-274.
12. Capanni C, Cenni V, Mattioli E, Sabatelli P, Ognibene A, Columbaro M, Parnaik VK, Wehnert M, Maraldi NM, Squarzoni S, Lattanzi G. 2003. Failure of lamin A/C to functionally assemble in R482L mutated familial partial lipodystrophy fibroblasts: Altered intermolecular interaction with emerin and implications for gene transcription. Exp Cell Res 291:122-134.
13. Caux F, Dubosclard E, Lascols O, Buendia B, Chazouilleres O, Cohen A, Courvalin JC, Laroche L, Capeau J, Vigouroux C, Christin-Maitre S. 2003. A new clinical condition linked to a novel mutation in lamins A and C with generalized lipoatrophy, insulin-resistant diabetes, disseminated leukomelanodermic papules, liver steatosis, and cardiomyopathy. J Clin Endocrinol Metab 88:1006-1013.
14. Chen L, Lee L, Kudlow BA, Dos Santos HG, Sletvold O, Shafeghati Y, Botha EG, Garg A, Hanson NB, Martin GM, Mian IS, Kennedy BK, Oshima J. 2003. LMNA mutations in atypical Werner's syndrome. Lancet 362:440-445.
15. Costa ML, Escaleira R, Cataldo A, Oliveira F, Mermelstein CS. 2004. Desmin: Molecular interactions and putative functions of the muscle intermediate filament protein. Braz J Med Biol Res 37:1819-1830.
16. De Sandre-Giovannoli A, Bernard R, Cau P, Navarro C, Amiel J, Boccaccio I, Lyonnet S, Stewart CL, Munnich A, Le Merrer M, Levy N. 2003. Lamin a truncation in Hutchinson-Gilford progeria. Science 300:2055.
17. Dhe-Paganon S, Werner ED, Chi YI, Shoelson SE. 2002. Structure of the globular tail of nuclear lamin. J Biol Chem 277:17381-17384.
18. Dreuillet C, Tillit J, Kress M, Ernoult-Lange M. 2002. In vivo and in vitro interaction between human transcription factor MOK2 and nuclear lamin A/C. Nucleic Acids Res 30:4634-4642.
19. Eriksson M, Brown WT, Gordon LB, Glynn MW, Singer J, Scott L, Erdos MR, Robbins CM, Moses TY, Berglund P, Dutra A, Pak E, Durkin S, Csoka AB, Boehnke M, Glover TW, Collins FS. 2003. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature 423:293-298.
20. Fatkin D, MacRae C, Sasaki T, Wolff MR, Porcu M, Frenneaux M, Atherton J, Vidaillet HJ, Jr., Spudich S, De Girolami U, Seidman JG, Seidman C, Muntoni F, Muehle G, Johnson W, McDonough B. 1999. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med 341:1715-1724.
21. Favreau C, Dubosclard E, Ostlund C, Vigouroux C, Capeau J, Wehnert M, Higuet D, Worman HJ, Courvalin JC, Buendia B. 2003. Expression of lamin A mutated in the carboxyl-terminal tail generates an aberrant nuclear phenotype similar to that observed in cells from patients with Dunnigan-type partial lipodystrophy and Emery-Dreifuss muscular dystrophy. Exp Cell Res 282:14-23.
22. Forwood JK, Jans DA. 2002. Nuclear import pathway of the telomere elongation suppressor TRF1: Inhibition by importin alpha. Biochemistry 41:9333-9340.
23. Ghildyal R, Ho A, Wagstaff KM, Dias MD, Barton CL, Jans P, Bardin P, Jans DA. 2005. Nuclear import of the respiratory syncytial virus matrix protein is mediated by importin1 independent of importin. Biochemistry 44:12887-12895.
24. Gilchrist S, Gilbert N, Perry P, Ostlund C, Worman HJ, Bickmore WA. 2004. Altered protein dynamics of disease-associated lamin A mutants. BMC Cell Biol 5:46.
25. Glass JR, Gerace L. 1990. Lamins A and C bind and assemble at the surface of mitotic chromosomes. J Cell Biol 111:1047-1057.
26. Goldberg M, Harel A, Brandeis M, Rechsteiner T, Richmond TJ, Weiss AM, Gruenbaum Y. 1999. The tail domain of lamin Dmo binds histones H2A and H2B. Proc Natl Acad Sci USA 96:2852-2857.
27. Goldman RD, Shumaker DK, Erdos MR, Eriksson M, Goldman AE, Gordon LB, Gruenbaum Y, Khuon S, Mendez M, Varga R, Collins FS. 2004. Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci USA 101:8963-8968.
28. Goldman RD, Goldman AE, Shumaker DK. 2005. Nuclear lamins: Building blocks of nuclear structure and function. Novartis Found Symp 264:3-16; discussion 16-21, 227-230.
29. Hoger TH, Krohne G, Kleinschmidt JA. 1991. Interaction of Xenopus lamins A and LII with chromatin in vitro mediated by a sequence element in the carboxyterminal domain. Exp Cell Res 197:280-289.
30. Holt I, Clements L, Manilal S, Brown SC, Morris GE. 2001. The R482Q lamin A/C mutation that causes lipodystrophy does not prevent nuclear targeting of lamin A in adipocytes or its interaction with ernenn. Eur J Hum Genet 9:204-208.
31. Holt I, Ostlund C, Stewart CL, Man N, Worman HJ, Morris GE. 2003. Effect of pathogenic missense mutations in lamin A on its interaction with ernenn in vivo. J Cell Sci 116:3027-3035.
32. Hozak P, Sasseville AM, Raymond Y, Cook PR. 1995. Lamin proteins form an internal nucleoskeleton as well as a peripheral lamina in human cells. J Cell Sci 108(Pt 2):635-644.
33. Hu W, Jans DA. 1999. Efficiency of importin alpha/beta-mediated nuclear localization sequence recognition and nuclear import. Differential role of NTF2. J Biol Chem 274:15820-15827.
34. Hübner S, Eam JE, Hübner A, Jans DA. 2006. Laminopathy-inducing lamin A mutants can induce redistribution of lamin binding proteins into nuclear aggregates. Exp Cell Res 312:171-183.
35. Izumi M, Vaughan OA, Hutchison CJ, Gilbert DM. 2000. Head and/or CaaX domain deletions of lamin proteins disrupt preformed lamin A and C but not lamin B structure in mammalian cells. Mol Biol Cell 11:4323-4337.
36. Jagatheesan G, Thanumalayan S, Muralikrishna B, Rangaraj N, Karande AA, Parnaik VK. 1999. Colocalization of intranuclear lamin foci with RNA splicing factors. J Cell Sci 112(Pt24):4651-4661.
37. Kennedy BK, Barbie DA, Classon M, Dyson N, Harlow E. 2000. Nuclear organization of DNA replication in primary mammalian cells. Genes Dev 14:2855-2868.
38. Koyama Y, Goldman JE. 1999. Formation of GFAP cytoplasmic inclusions in astrocytes and their disaggregation by alpha B-crystallin. Am J Pathol 154:1563-1572.
39. Krimm I, Ostlund C, Gilquin B, Couprie J, Hossenlopp P, Mornon JP, Bonne G, Courvalin JC, Worman HJ, Zinn-Justin S. 2002. The Ig-like structure of the C-terminal domain of laminA/C, mutated in muscular dystrophies, cardiomyopathy, and partial lipodystrophy. Structure (Camb) 10:811-823.
40. Lammerding J, Schulze PC, Takahashi T, Kozlov S, Sullivan T, Kamm RD, Stewart CL, Lee RT. 2004. Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction. J Clin Invest 113:370-378.
41. Lenz-Bohme B, Wismar J, Fuchs S, Reifegerste R, Buchner E, Betz H, Schmitt B. 1997. Insertional mutation of the Drosophila nuclear lamin Dmo gene results in defective nuclear envelopes, clustering of nuclear pore complexes, and accumulation of annulate lamellae. J Cell Biol 137:1001-1016.
42. Liu J, Ben-Shahar TR, Riemer D, Treinin M, Spann P, Weber K, Fire A, Gruenbaum Y. 2000. Essential roles for Caenorhabditis elegans lamin gene in nuclear organization, cell cycle progression, and spatial organization of nuclear pore complexes. Mol Biol Cell 11:3937-3947.
43. Lloyd DJ, Trembath RC, Shackleton S. 2002. A novel interaction between lamin A and SREBP1: Implications for partial lipodystrophy and other laminopathies. Hum Mol Genet 11:769-777.
44. Machiels BM, Broers JL, Raymond Y, de Ley L, Kuijpers HJ, Caberg NE, Ramaekers FC. 1995. Abnormal A-type lamin organization in a human lung carcinoma cell line. Eur J Cell Biol 67:328-335.
45. Markiewicz E, Dechat T, Foisner R, Quinlan RA, Hutchison CJ. 2002a. Lamin A/C binding protein LAP2alpha is required for nuclear anchorage of retinoblastoma protein. Mol Biol Cell 13:4401-4413.
46. Markiewicz E, Venables R, Mauricio Alvarez R, Quinlan R, Dorobek M, Hausmanowa-Petrucewicz I, Hutchison C. 2002b. Increased solubility of lamins and redistribution of lamin C in X-linked Emery-Dreifuss muscular dystrophy fibroblasts. J Struct Biol 140:241-253.
47. Moir RD, Montag-Lowy M, Goldman RD. 1994. Dynamic properties of nuclear lamins: Lamin B is associated with sites of DNA replication. J Cell Biol 125:1201-1212.
48. Mosammaparast N, Jackson KR, Guo Y, Brame CJ, Shabanowitz J, Hunt DF, Pemberton LF. 2001. Nuclear import of histone H2A and H2B is mediated by a network of karyopherins. J Cell Biol 153:251-262.
49. Muchir A, van Engelen BG, Lammens M, Mislow JM, McNally E, Schwartz K, Bonne G. 2003. Nuclear envelope alterations in fibroblasts from LGMD1B patients carrying nonsense Y259X heterozygous or homozygous mutation in lamin A/C gene. Exp Cell Res 291:352-362.
50. Muchir A, Medioni J, Laluc M, Massart C, Arimura T, van der Kooi AJ, Desguerre I, Mayer M, Ferrer X, Briault S, Hirano M, Worman HJ, Mallet A, Wehnert M, Schwartz K, Bonne G. 2004. Nuclear envelope alterations in fibroblasts from patients with muscular dystrophy, cardiomyopathy, and partial lipodystrophy carrying lamin A/C gene mutations. Muscle Nerve 30:444-450.
51. Muhlhausser P, Muller EC, Otto A, Kutay U. 2001. Multiple pathways contribute to nuclear import of core histones. EMBO Rep 2:690-696.
52. Muralikrishna B, Thanumalayan S, Jagatheesan G, Rangaraj N, Karande AA, Parnaik VK. 2004. Immunolocalization of detergent-susceptible nucleoplasmic lamin A/C foci by a novel monoclonal antibody. J Cell Biochem 91:730-739.
53. Neri LM, Raymond Y, Giordano A, Borgatti P, Marchisio M, Capitani S, Martelli AM. 1999. Spatial distribution of lamin A and B1 in the K562 cell nuclear matrix stabilized with metal ions. J Cell Biochem 75:36-45.
54. Newport JW, Wilson KL, Dunphy WG. 1990. A lamin-independent pathway for nuclear envelope assembly. J Cell Biol 111:2247-2259.
55. Nikolova V, Leimena C, McMahon AC, Tan JC, Chandar S, Jogia D, Kesteven SH, Michalicek J, Otway R, Verheyen F, Rainer S, Stewart CL, Martin D, Feneley MP, Fatkin D. 2004. Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/C deficient mice. J Clin Invest 113:357-369.
56. Novelli G, Muchir A, Sangiuolo F, Helbling-Leclerc A, D'Apice MR, Massart C, Capon F, Sbraccia P, Federici M, Lauro R, Tudisco C, Pallotta R, Scarano G, Dallapiccola B, Merlini L, Bonne G. 2002. Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A/C. Am J Hum Genet 71:426-431.
57. Ostlund C, Bonne G, Schwartz K, Worman HJ. 2001. Properties of lamin A mutants found in Emery-Dreifuss muscular dystrophy, cardiomyopathy and Dunnigan-type partiall lipodystrophy. J Cell Sci 114:4435-4445.
58. Ozaki T, Saijo M, Murakami K, Enomoto H, Taya Y, Sakiyama S. 1994. Complex formation between lamin A and the retinoblastoma gene product: Identification of the domain on laminA required for its interaction. Oncogene 9:2649-2653.
59. Piechaczek C, Fetzer C, Baiker A, Bode J, Lipps HJ. 1999. A vector based on the SV40 origin of replication and chromosomal S/MARs replicates episomally in CHO cells. Nucleic Acids Res 27:426-428.
60. Pugh GE, Coates PJ, Lane EB, Raymond Y, Quinlan RA. 1997. Distinct nuclear assembly pathways for lamins A and C lead to their increase during quiescence in Swiss 3T3 cells. J Cell Sci 110(Pt 19):2483-2493.
61. Raharjo WH, Enarson P, Sullivan T, Stewart CL, Burke B. 2001. Nuclear envelope defects associated with LMNA mutations cause dilated cardiomyopathy and Emery-Dreifuss muscular dystrophy. J Cell Sci 114:4447-4457.
62. Sasse B, Lustig A, Aebi U, Stuurman N. 1997. In vitro assembly of Drosophila lamin Dmo-lamin polymerization properties are conserved. Eur J Biochem 250:30-38.
63. Sasseville AM, Raymond Y. 1995. Lamin A precursor is localized to intranuclear foci. J Cell Sci 108(Pt 1):273-285.
64. Schirmer EC, Gerace L. 2004. The stability of the nuclear lamina polymer changes with the composition of lamin subtypes according to their individual binding strengths. J Biol Chem 279:42811-42817.
65. Sebillon P, Bouchier C, Bidot LD, Bonne G, Ahamed K, Charron P, Drouin-Garraud V, Millaire A, Desrumeaux G, Benaiche A, Charniot JC, Schwartz K, Villard E, Komajda M. 2003. Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and functional consequences of these mutations. J Med Genet 40:560-567.
66. Shackleton S, Lloyd DJ, Jackson SN, Evans R, Niermeijer MF, Singh BM, Schmidt H, Brabant G, Kumar S, Durrington PN, Gregory S, O'Rahilly S, Trembath RC. 2000. LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nat Genet 24:153-156.
67. Sinensky M, Fantle K, Trujillo M, McLain T, Kupfer A, Dalton M. 1994a. The processing pathway of prelamin A. J Cell Sci 107(Pt 1):61-67.
68. Sinensky M, McLain T, Fantle K. 1994b. Expression of prelamin A but not mature lamin A confers sensitivity of DNA biosynthesis to lovastatin on F9 teratocarcinoma cells. J Cell Sci 107(Pt 8):2215-2218.
69. Soboleva TA, Jans DA, Johnson-Saliba M, Baker RT. 2005. Nuclear-cytoplasmic shuttling of the oncogenic mouse UNP/USP4 deubiquitylating enzyme. J Biol Chem 280:745-752.
70. Spann TP, Moir RD, Goldman AE, Stick R, Goldman RD. 1997. Disruption of nuclear lamin organization alters the distribution of replication factors and inhibits DNA synthesis. J Cell Biol 136:1201-1212.
71. Stierle V, Couprie J, Ostlund C, Krimm I, Zinn-Justin S, Hossenlopp P, Worman HJ, Courvalin JC, Duband-Goulet I. 2003. The carboxyl-terminal region common to lamins A and C contains a DNA binding domain. Biochemistry 42:4819-4828.
72. Strelkov SV, Schumacher J, Burkhard P, Aebi U, Herrmann H. 2004. Crystal structure of the human lamin A coil 2B dimer: Implications for the head-to-tail association of nuclear lamins. J Mol Biol 343:1067-1080.
73. Stuurman N, Sasse B, Fisher PA. 1996. Intermediate filament protein polymerization: Molecular analysis of Drosophila nuclear lamin head-to-tail binding. J Struct Biol 117:1-15.
74. Sullivan T, Escalante-Alcalde D, Bhatt H, Anver M, Bhat N, Nagashima K, Stewart CL, Burke B. 1999. Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J Cell Biol 147:913-920.
75. Taniura H, Glass C, Gerace L. 1995. A chromatin binding site in the tail domain of nuclear lamins that interacts with core histones. J Cell Biol 131:33-44.
76. Vigouroux C, Auclair M, Dubosclard E, Pouchelet M, Capeau J, Courvalin JC, Buendia B. 2001. Nuclear envelope disorganization in fibroblasts from lipodystrophic patients with heterozygous R482Q/W mutations in the lamin A/C gene. J Cell Sci 114:4459-4468.
77. Weber K, Plessmann U, Traub P. 1989. Maturation of nuclear lamin A involves a specific carboxy-terminal trimming, which removes the polyisoprenylation site from the precursor; implications for the structure of the nuclear lamina. FEBS Lett 257:411-414.
78. Yuan J, Simos G, Blobel G, Georgatos SD. 1991. Binding of lamin A to polynucleosomes. J Biol Chem 266:9211-9215.